date:Aug 03, 2012
2002 licensing agreement. DuPont countersued, alleging anticompetitive practices. DuPont has since shelved the Optimum GAT product.
During the trial, DuPont, based in Wilmington, Del., argued that Monsanto misled U.S. government officials to obtain the patent.
This verdict highlights that all companies that make early and substantial investments in developing cutting-edge technology will have their intellectual property rights upheld and fairly valued, said David Snively, Monsanto's Executive V